Overview and Resources: The Tissue Culture function has been in place since the original grant in 1997, although it has expanded considerably in response to changing needs of VSRC investigators. Dawn Smith has been managing this Module since 2002 and has risen to the challenge of increased and more diverse needs. In the last 2-3 years, the Module has also offered transfection services, and Ms. Smith routinely and successfully uses lipofectamine to transfect cell lines for several investigators. The Hybridoma facility was incorporated in August 2006 to meet an increased need for generating new monoclonal antibodies in addition to propagation of established hybridoma lines. In the renewal, we also include monoclonal antibody purification using protein A, G and M columns to provide investigators with a high concentration of antibody free from culture contaminants, especially serum components. Denice Major has been running this Module since its inception, and will continue to provide expert technical support in all these areas. The TCH Module is located in the consolidated VSRC Core Grant facility research area in the Institute of Pathology building of the Case School of Medicine. The main laboratory has two laminar flow hoods and incubators, and the BSL2 room has a separate hood and incubator for BSL2 functions.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Center Core Grants (P30)
Project #
2P30EY011373-16
Application #
8434359
Study Section
Special Emphasis Panel (ZEY1-VSN (10))
Project Start
Project End
Budget Start
2012-09-30
Budget End
2013-08-31
Support Year
16
Fiscal Year
2012
Total Cost
$163,164
Indirect Cost
$59,238
Name
Case Western Reserve University
Department
Type
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Gragg, Megan; Park, Paul S-H (2018) Misfolded rhodopsin mutants display variable aggregation properties. Biochim Biophys Acta Mol Basis Dis 1864:2938-2948
Parmar, Vipul M; Parmar, Tanu; Arai, Eisuke et al. (2018) A2E-associated cell death and inflammation in retinal pigmented epithelial cells from human induced pluripotent stem cells. Stem Cell Res 27:95-104
Cheng, Yu-Shiuan; Linetsky, Mikhail; Gu, Xilin et al. (2018) Light-induced generation and toxicity of docosahexaenoate-derived oxidation products in retinal pigmented epithelial cells. Exp Eye Res :
Palczewska, Grazyna; Stremplewski, Patrycjusz; Suh, Susie et al. (2018) Two-photon imaging of the mammalian retina with ultrafast pulsing laser. JCI Insight 3:
Mallory, D Paul; Gutierrez, Elizabeth; Pinkevitch, Margaret et al. (2018) The Retinitis Pigmentosa-Linked Mutations in Transmembrane Helix 5 of Rhodopsin Disrupt Cellular Trafficking Regardless of Oligomerization State. Biochemistry 57:5188-5201
Linetsky, Mikhail; Bondelid, Karina S; Losovskiy, Sofiya et al. (2018) 4-Hydroxy-7-oxo-5-heptenoic Acid Lactone Is a Potent Inducer of the Complement Pathway in Human Retinal Pigmented Epithelial Cells. Chem Res Toxicol 31:666-679
Choi, Elliot H; Suh, Susie; Sander, Christopher L et al. (2018) Insights into the pathogenesis of dominant retinitis pigmentosa associated with a D477G mutation in RPE65. Hum Mol Genet 27:2225-2243
Zhang, Lingjun; Li, Yan; Qiu, Wen et al. (2018) Targeting CD6 for the treatment of experimental autoimmune uveitis. J Autoimmun 90:84-93
Orban, Tivadar; Leinonen, Henri; Getter, Tamar et al. (2018) A Combination of G Protein-Coupled Receptor Modulators Protects Photoreceptors from Degeneration. J Pharmacol Exp Ther 364:207-220
Samanta, Amrita; Kiselar, Janna; Pumroy, Ruth A et al. (2018) Structural insights into the molecular mechanism of mouse TRPA1 activation and inhibition. J Gen Physiol 150:751-762

Showing the most recent 10 out of 510 publications